Literature DB >> 7004039

Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.

S Del Prato, F Riva, A Devidé, R Nosadini, D Fedele, A Tiengo.   

Abstract

In three groups of patients with insulin-dependent diabetes following total (n = 5) or partial (n = 5) pancreatectomy or chronic pancreatitis (n = 7) and in a group of idiopathic diabetics, ketogenic capacity following insulin withdrawal and during a 24-h fast was studied. Basal glucagon values were significantly increased in all diabetic groups with no significant intergroup differences. Basal ketone body values and their increase during starvation and insulin withdrawal were high and not different in totally pancreatectomized and primary diabetics, both showing unmeasurable C-peptide levels. On the contrary, ketogenesis was reduced in partially pancreatectomized and in pancreatitis diabetics with persistent levels of C-peptide. Our data confirmed the persistence of immunoreactive glucagon after pancreatectomy and demonstrated that ketogenesis is not suppressed in pancreatectomized diabetics and depends above all on residual B-cell function. A possible ketogenic effect of extra-pancreatic glucagon-like substances cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004039     DOI: 10.1007/bf02580992

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  35 in total

1.  [Comparison of glucagon secretions in diabetes mellitus with or without acquired organic pancreatopathy].

Authors:  R Assan; A Tiengo
Journal:  Pathol Biol (Paris)       Date:  1973-01

2.  Plasma glucose, insulin, pancreatic, and enteroglucagon levels in normal and depancreatized dogs.

Authors:  T Matsuyama; P P Foà
Journal:  Proc Soc Exp Biol Med       Date:  1974-10

3.  Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.

Authors:  M Vranic; S Pek; R Kawamori
Journal:  Diabetes       Date:  1974-11       Impact factor: 9.461

4.  Glucagon secretion in acute and chronic pancreatitis.

Authors:  M Donowitz; R Hendler; H M Spiro; H J Binder; P Felig
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

5.  Plasma glucagon after total resection of the pancreas in man.

Authors:  M Miyata; T Yamamoyo; M Yamaguchi; K Nakao; T Yoshida
Journal:  Proc Soc Exp Biol Med       Date:  1976-09

6.  The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats.

Authors:  J C Dunbar; M F Walsh; P P Foà
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

7.  Properties of immunoreactive glucagon fractions of canine stomach and pancreas.

Authors:  C B Srikant; K McCorkle; R H Unger
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

8.  Ketoacidosis in pancreatectomized man.

Authors:  A J Barnes; S R Bloom; K Goerge; G M Alberti; P Smythe; F P Alford; D J Chisholm
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

9.  Identical biological effects of pancreatic glucagon and a purified moiety of canine gastric immunoreactive glucagon.

Authors:  K Doi; M Prentki; C Yip; W A Muller; B Jeanrenaud; M Vranic
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

10.  Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs.

Authors:  J J Holst; M Kreutzfeldt; G Holm; E Jensen; J S Poulsen; B Sparsö; B Sparsö; A Schmidt
Journal:  Diabete Metab       Date:  1978-06
View more
  7 in total

1.  Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis.

Authors:  T Nakamura; K Imamura; K Takebe; A Terada; Y Arai; Y Tandoh; N Yamada; M Ishii; K Machida; T Suda
Journal:  Int J Pancreatol       Date:  1996-12

2.  Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.

Authors:  S Del Prato; S Vigili de Kreutzenberg; R Trevisan; E Duner; A Avogaro; R Nosadini; U Baccaglini; C Tremolada; A Tiengo
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

Review 3.  Diabetes after pancreatic surgery: novel issues.

Authors:  Marina Scavini; Erica Dugnani; Valentina Pasquale; Daniela Liberati; Francesca Aleotti; Gaetano Di Terlizzi; Giovanna Petrella; Gianpaolo Balzano; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

4.  Failure of glucagon to stimulate ketone body production during acute insulin deficiency or insulin replacement in man.

Authors:  G E Sonnenberg; W Stauffacher; U Keller
Journal:  Diabetologia       Date:  1982-08       Impact factor: 10.122

5.  Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy.

Authors:  S Del Prato; A Tiengo; U Baccaglini; C Tremolada; E Duner; M C Marescotti; A Avogaro; I Valverde; R Nosadini; R Assan
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

6.  Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.

Authors:  Young Lee; May-Yun Wang; Xiu Quan Du; Maureen J Charron; Roger H Unger
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

7.  The Metabolic Responses to L-Glutamine of Livers from Rats with Diabetes Types 1 and 2.

Authors:  Jurandir Fernando Comar; Denise Silva de Oliveira; Livia Bracht; Fumie Suzuki Kemmelmeier; Rosane Marina Peralta; Adelar Bracht
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.